These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33721346)
21. Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata. Zhang X; Zhao Y; Ye Y; Li S; Qi S; Yang Y; Cao H; Yang J; Zhang X Arch Dermatol Res; 2015 May; 307(4):319-31. PubMed ID: 25638328 [TBL] [Abstract][Full Text] [Related]
22. The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature. Pavel AB; Zhou L; Diaz A; Ungar B; Dan J; He H; Estrada YD; Xu H; Fernandes M; Renert-Yuval Y; Krueger JG; Guttman-Yassky E J Am Acad Dermatol; 2020 Mar; 82(3):690-699. PubMed ID: 31669080 [TBL] [Abstract][Full Text] [Related]
23. Increased expression of TLR7 and TLR9 in alopecia areata. Kang H; Wu WY; Yu M; Shapiro J; McElwee KJ Exp Dermatol; 2020 Mar; 29(3):254-258. PubMed ID: 31571275 [TBL] [Abstract][Full Text] [Related]
24. Diffuse alopecia areata is associated with intense inflammatory infiltration and CD8+ T cells in hair loss regions and an increase in serum IgE level. Zhao Y; Zhang B; Caulloo S; Chen X; Li Y; Zhang X Indian J Dermatol Venereol Leprol; 2012; 78(6):709-14. PubMed ID: 23075639 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic implications of MicroRNAs; 155, 146 a, and 203 lesional expression in alopecia areata: A preliminary case-controlled study. Mustafa AI; Al-Refaie AM; El-Shimi OS; Fawzy E; Sorour NE J Cosmet Dermatol; 2022 Jun; 21(6):2648-2654. PubMed ID: 34564949 [TBL] [Abstract][Full Text] [Related]
26. Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata. Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Mesinkovska N; Ko JM; King BA Qual Life Res; 2023 May; 32(5):1319-1327. PubMed ID: 35821174 [TBL] [Abstract][Full Text] [Related]
27. Changes and significance of Th1/Th2 and Treg/Th17 cells and their cytokines in patients with alopecia areata. Yang X; Zhang W; Zhao X; Hou W; Wu Y; Feng D; Meng Z; Zhou X Exp Cell Res; 2024 Oct; 442(2):114259. PubMed ID: 39293523 [TBL] [Abstract][Full Text] [Related]
28. Development of the Scalp Hair Assessment PRO™ measure for alopecia areata. Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA Br J Dermatol; 2020 Dec; 183(6):1065-1072. PubMed ID: 32163589 [TBL] [Abstract][Full Text] [Related]
29. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents. Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274 [TBL] [Abstract][Full Text] [Related]
30. Prediction of the Risk of Alopecia Areata Progressing to Alopecia Totalis and Alopecia Universalis: Biomarker Development with Bioinformatics Analysis and Machine Learning. Zhang T; Nie Y Dermatology; 2022; 238(2):386-396. PubMed ID: 34004600 [TBL] [Abstract][Full Text] [Related]
31. Association Between Scalp Microbiota Imbalance, Disease Severity, and Systemic Inflammatory Markers in Alopecia Areata. Gómez-Arias PJ; Gay-Mimbrera J; Rivera-Ruiz I; Aguilar-Luque M; Juan-Cencerrado M; Mochón-Jiménez C; Gómez-García F; Sánchez-González S; Ortega-Hernández A; Gómez-Garre D; Parra-Peralbo E; Isla-Tejera B; Ruano J Dermatol Ther (Heidelb); 2024 Nov; 14(11):2971-2986. PubMed ID: 39384736 [TBL] [Abstract][Full Text] [Related]
32. CCL13 is upregulated in alopecia areata lesions and is correlated with disease severity. Wang D; Xu X; Li X; Shi J; Tong X; Chen J; Lu J; Huang J; Yang S Exp Dermatol; 2021 May; 30(5):723-732. PubMed ID: 33523560 [TBL] [Abstract][Full Text] [Related]
33. Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity. Sayed Mahmoud Marie RE; Abd El-Fadeel NM; El-Sayed Marei Y; Atef LM Dermatol Res Pract; 2022; 2022():5004642. PubMed ID: 35300124 [TBL] [Abstract][Full Text] [Related]
34. Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm. Daroach M; Narang T; Saikia UN; Sachdeva N; Sendhil Kumaran M Int J Dermatol; 2018 Feb; 57(2):217-222. PubMed ID: 29243839 [TBL] [Abstract][Full Text] [Related]
35. Serum level of interleukin-17A in patients with alopecia areata and its relationship to age. El-Morsy EH; Eid AA; Ghoneim H; Al-Tameemi KA Int J Dermatol; 2016 Aug; 55(8):869-74. PubMed ID: 26475394 [TBL] [Abstract][Full Text] [Related]
36. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367 [TBL] [Abstract][Full Text] [Related]
37. Detection of Tumor Necrosis Factor-alpha in Nonlesional Tissues of Alopecia Areata Patients: A Prove for a Systemic Disease. Gohary YM; Abdel Fattah DS Int J Trichology; 2017; 9(4):154-159. PubMed ID: 29118519 [TBL] [Abstract][Full Text] [Related]
38. Acute diffuse and total alopecia of the female scalp. A new subtype of diffuse alopecia areata that has a favorable prognosis. Sato-Kawamura M; Aiba S; Tagami H Dermatology; 2002; 205(4):367-73. PubMed ID: 12444333 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata. Salem SA; Asaad MK; Elsayed SB; Sehsah HM Int J Dermatol; 2016 Dec; 55(12):1357-1361. PubMed ID: 27420731 [TBL] [Abstract][Full Text] [Related]
40. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS J Invest Dermatol; 2001 Dec; 117(6):1357-62. PubMed ID: 11886495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]